ASX - By Stock
|
ATX |
Re:
Ann: Trading Halt
|
|
ThriftyClown
|
41 |
9.6K |
1 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
41
|
9.6K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Trading Halt
|
|
ThriftyClown
|
41 |
9.6K |
3 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
41
|
9.6K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
ThriftyClown
|
26 |
5.2K |
23 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
26
|
5.2K
|
23
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Report and Shareholder Update
|
|
ThriftyClown
|
1 |
793 |
1 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
1
|
793
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Why is our SP so low?
|
|
ThriftyClown
|
38 |
8.9K |
5 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
38
|
8.9K
|
5
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ATX FAK Inhibitors Reduce Fibrosis in Animal Model of NASH
|
|
ThriftyClown
|
16 |
4.4K |
5 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
16
|
4.4K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
ThriftyClown
|
732 |
147K |
12 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
732
|
147K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
ThriftyClown
|
732 |
147K |
10 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
732
|
147K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
ThriftyClown
|
732 |
147K |
18 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
732
|
147K
|
18
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Appoints New Non-Executive Director
|
|
ThriftyClown
|
8 |
2.0K |
5 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
8
|
2.0K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
MY INPUT REGARDING PAA AND SARS-COV-2.
|
|
ThriftyClown
|
41 |
9.4K |
9 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
41
|
9.4K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
MY INPUT REGARDING PAA AND SARS-COV-2.
|
|
ThriftyClown
|
41 |
9.4K |
7 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
41
|
9.4K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
MY INPUT REGARDING PAA AND SARS-COV-2.
|
|
ThriftyClown
|
41 |
9.4K |
13 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
41
|
9.4K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
ThriftyClown
|
732 |
147K |
5 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
732
|
147K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ThriftyClown
|
39 |
10K |
4 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
39
|
10K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ThriftyClown
|
39 |
10K |
29 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
39
|
10K
|
29
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on Phase IIb Clinical Trial of Monepantel in Pet Dogs
|
|
ThriftyClown
|
56 |
11K |
20 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
56
|
11K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
PPL-1 and results with my dog
|
|
ThriftyClown
|
189 |
41K |
7 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
189
|
41K
|
7
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia and Garvan Institute Enter Collaboration Agreement
|
|
ThriftyClown
|
11 |
3.0K |
6 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
11
|
3.0K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
ThriftyClown
|
1.4K |
317K |
6 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
1.4K
|
317K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
ThriftyClown
|
1.4K |
317K |
11 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
1.4K
|
317K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
ThriftyClown
|
1.4K |
317K |
6 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
1.4K
|
317K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
ThriftyClown
|
1.4K |
317K |
9 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
1.4K
|
317K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
ThriftyClown
|
1.4K |
317K |
9 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
1.4K
|
317K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
ThriftyClown
|
1.4K |
317K |
15 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
1.4K
|
317K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
ThriftyClown
|
1.4K |
317K |
7 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
1.4K
|
317K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
ThriftyClown
|
1.4K |
317K |
27 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
1.4K
|
317K
|
27
|
|
Charts
|
ATX |
Re:
Atx chart
|
|
ThriftyClown
|
7 |
3.1K |
3 |
26/02/21 |
26/02/21 |
Charts
|
7
|
3.1K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Currently in Holland
|
|
ThriftyClown
|
3 |
1.1K |
13 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
3
|
1.1K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on Phase IIb Clinical Trial recruitment
|
|
ThriftyClown
|
20 |
6.5K |
13 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
20
|
6.5K
|
13
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Investor Update - February 2021
|
|
ThriftyClown
|
9 |
3.2K |
9 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
9
|
3.2K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
ThriftyClown
|
106 |
18K |
15 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
106
|
18K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
ThriftyClown
|
106 |
18K |
6 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
106
|
18K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
ThriftyClown
|
106 |
18K |
5 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
106
|
18K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
ThriftyClown
|
106 |
18K |
21 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
106
|
18K
|
21
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities and Cashflow Reports - Dec 2020 Qtr
|
|
ThriftyClown
|
10 |
2.7K |
7 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
10
|
2.7K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden University Medical Centre Monepantel COVID-19 Testing
|
|
ThriftyClown
|
105 |
22K |
12 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
105
|
22K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden University Medical Centre Monepantel COVID-19 Testing
|
|
ThriftyClown
|
105 |
22K |
8 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
105
|
22K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden University Medical Centre Monepantel COVID-19 Testing
|
|
ThriftyClown
|
105 |
22K |
8 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
105
|
22K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden University Medical Centre Monepantel COVID-19 Testing
|
|
ThriftyClown
|
105 |
22K |
13 |
09/01/21 |
09/01/21 |
ASX - By Stock
|
105
|
22K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to Commence Phase IIb Dog Cancer Trial
|
|
ThriftyClown
|
79 |
19K |
14 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
79
|
19K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Some scientific inspiration
|
|
ThriftyClown
|
27 |
5.1K |
9 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
27
|
5.1K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 2A & s708 notice (exercise of options)
|
|
ThriftyClown
|
19 |
3.7K |
5 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
19
|
3.7K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 2A & s708 notice (exercise of options)
|
|
ThriftyClown
|
19 |
3.7K |
8 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
19
|
3.7K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Trial results discussion
|
|
ThriftyClown
|
121 |
23K |
25 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
121
|
23K
|
25
|
|
ASX - By Stock
|
PAA Biotech |
Re:
copy of PAA AGM questions and answers
|
|
ThriftyClown
|
116 |
21K |
3 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
116
|
21K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
copy of PAA AGM questions and answers
|
|
ThriftyClown
|
116 |
21K |
15 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
116
|
21K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
ThriftyClown
|
78 |
11K |
11 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
78
|
11K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PharmAust - Now that is impressive
|
|
ThriftyClown
|
120 |
34K |
7 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
120
|
34K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
HC PAA SH Volume
|
|
ThriftyClown
|
180 |
40K |
10 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
180
|
40K
|
10
|
|